睫毛粗长症:获得性与先天性睫毛增长病因的系统综述
本系统综述通过检索截至2021年1月的Medline/PubMed和Cochrane图书馆,纳入148项临床试验、前瞻性与回顾性研究及病例报告,总结睫毛粗长症的获得性与先天性病因。药物相关病因包括前列腺素类似物、表皮生长因子受体抑制剂、干扰素α和钙调神经磷酸酶抑制剂;还涉及眼睑手术、过敏性疾病、感染及多种先天综合征。最常见病因为局部比马前列素使用。
要点
- 药物相关睫毛粗长症涉及前列腺素类似物、EGFR抑制剂、干扰素α和钙调神经磷酸酶抑制剂。
- 获得性病因还包括眼睑手术、过敏性鼻炎、特应性皮炎、HIV、寻常型鱼鳞病、葡萄膜炎和春季角结膜炎。
- 先天性病因包括Cantú综合征、CHOPS综合征、Coffin-Siris综合征等多种遗传综合征。
核心结论
- 睫毛粗长症的最常见病因是局部比马前列素使用。
- 更好地理解睫毛粗长症相关通路可能有助于发现刺激睫毛生长的其他药物,并为未来治疗干预开辟途径。
研究设计与样本
- 系统综述,检索Medline/PubMed和Cochrane图书馆截至2021年1月的文献,纳入148项临床试验、前瞻性与回顾性研究及病例报告。
- 纳入标准为涉及先天性或获得性疾病以睫毛粗长症为特征的人体研究,或评估药物或操作导致睫毛粗长症为不良反应或期望效果的研究。
- 排除标准为动物研究、非英文文献、与睫毛粗长症无关的结果以及二次综述文章。
主要发现
- 药物相关病因包括前列腺素类似物(15-酮氟前列醇异丙酯、比马前列素、拉坦前列素和曲伏前列素)、表皮生长因子受体抑制剂(西妥昔单抗、厄洛替尼和帕尼单抗)、干扰素α和钙调神经磷酸酶抑制剂(他克莫司和环孢素)。
- 眼睑手术以及过敏性鼻炎、特应性皮炎、HIV、寻常型鱼鳞病、葡萄膜炎和春季角结膜炎也与睫毛生长增加相关。
- 先天性病因包括Cantú综合征、CHOPS综合征、Coffin-Siris综合征、先天性心脏病、Cornelia de Lange综合征、Costello综合征、家族性睫毛粗长症、Floating Harbor综合征、Hermansky-Pudlak综合征、歌舞伎化妆综合征、KBG综合征、Oliver-McFarlane综合征、Rubinstein-Taybi综合征和Smith-Magenis综合征。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Long eyelashes have been popularized and many commercially available products exist to achieve eyelash growth as a desired cosmetic effect. Eyelash trichomegaly may be induced by medications, procedures, or be related to medical conditions; however, the exact mechanisms that govern eyelash growth are not well elucidated. This study aims to identify and summarize aetiologies associated with eyelash trichomegaly. We report a systematic review of 148 clinical trials, prospective and retrospective studies, and case reports describing all evidence-based potential aetiologies of eyelash trichomegaly obtained from the Medline/PubMed and Cochrane Library through January 2021. Inclusion criteria were defined as (i) human studies involving congenital and acquired diseases in which eyelash trichomegaly is a characteristic or (ii) assessment of trichomegaly as an adverse or desired effect of a medication or procedure. Exclusion criteria included: animal studies, articles not available in English, outcomes unrelated to eyelash trichomegaly, and secondary review articles. Pharmacologic agents associated with eyelash trichomegaly included prostaglandin analogues (15-keto fluprostenol isopropyl ester, bimatoprost, latanoprost, and travoprost), epidermal growth factor receptor inhibitors (cetuximab, erlotinib, and panitumumab), interferon-alpha, and calcineurin inhibitors (tacrolimus and cyclosporine). Surgical procedures of the eyelid, as well as allergic rhinitis, atopic dermatitis, HIV, ichthyosis vulgaris (IV), uveitis, and vernal keratoconjunctivitis were also associated with increased eyelash growth. Congenital disorders associated with lengthened eyelashes included Cantú syndrome, CHOPS syndrome, Coffin-Siris syndrome, congenital heart disease, Cornelia de Lange syndrome, Costello syndrome, familial trichomegaly, Floating Harbor syndrome, Hermansky-Pudlak syndrome, Kabuki-Makeup syndrome, KBG syndrome, Oliver-McFarlane syndrome, Rubinstein-Taybi syndrome, and Smith-Magenis syndrome. While the most common cause of eyelash trichomegaly is topical bimatoprost use, better understanding of pathways implicated in eyelash trichomegaly may lead to the discovery of additional medications to stimulate eyelash growth and create avenues for future therapeutic interventions.
引用
- Hutchison DM, Duffens A, Yale K, et al. Eyelash trichomegaly: a systematic review of acquired and congenital aetiologies of lengthened lashes. J Eur Acad Dermatol Venereol. 2021. PMID: 34919300. doi:10.1111/jdv.17877
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。